a public good project by the
Synthesis
Company
of California

© 2026

Ron S. Broide | doi.page

0 works0 citations0 h-index

Ron S. Broide

AbbVie (United States)(US)Allergan (Ireland)(IE)Allergan (United States)(US)

Publications by Year

Research Areas

Botulinum Toxin and Related Neurological Disorders, Nicotinic Acetylcholine Receptors Study, Neurological disorders and treatments, Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research

Most-Cited Works

→ Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors.(1990)638 cited
→ Differential Desensitization and Distribution of Nicotinic Acetylcholine Receptor Subtypes in Midbrain Dopamine Areas(2003)361 cited
→ Distribution of histone deacetylases 1–11 in the rat brain(2007)349 cited
→ Nicotine and brain development(2008)255 cited
→ The α7 nicotinic acetylcholine receptor in neuronal plasticity(1999)210 cited
→ The Nicotinic Acetylcholine Receptor Subunit α5 Mediates Short-Term Effects of Nicotine in Vivo(2003)194 cited

→ Adult mouse brain gene expression patterns bear an embryologic imprint(2005)

186 cited

→ Nootropic α7 nicotinic receptor allosteric modulator derived from GABA _A receptor modulators(2007)165 cited

→ Mice Homozygous for the L250T Mutation in the α7 Nicotinic Acetylcholine Receptor Show Increased Neuronal Apoptosis and Die Within 1 Day of Birth(2000)132 cited

→ Developmental expression ofα7 neuronal nicotinic receptor messenger RNA in rat sensory cortex and thalamus(1995)131 cited